ドラッグデリバリー技術の世界市場レポート 2025年

ドラッグデリバリー技術市場規模は、今後数年で急成長が見込まれます。2029年の年間平均成長率（CAGR）は11.5％で、844億6,000万米ドルに成長します。予測期間中の成長は、個別化医療の増加、規制当局の承認数の増加、スマート・ドラッグ・デリバリー・システムの採用拡大、生分解性ドラッグ・キャリアの選好、希少疾患の有病率の上昇などに起因すると考えられます。予測期間中に予想される主な動向には、ナノテクノロジーの応用、患者中心のデリバリーシステム、吸入療法の進歩、ドラッグデリバリーへのバイオプリンティングの利用、人工知能の統合などがあります。

慢性疾患の有病率の増加は、ドラッグデリバリー技術市場の成長を加速させると予想されます。慢性疾患は、一般的にゆっくりと進行し、継続的な管理を必要とする長期的な病状です。慢性疾患の増加は、身体活動を低下させ、肥満やその他の関連する健康問題を引き起こす、座りがちなライフスタイルに大きく起因しています。ドラッグデリバリー技術は、ターゲットを絞ったドラッグデリバリー、放出制御、バイオアベイラビリティの向上、副作用の軽減を可能にし、最終的に治療効果、患者のアドヒアランス、疾病管理を強化することで、慢性疾患の管理に重要な役割を果たしています。例えば、2024年6月、オーストラリアの政府機関であるオーストラリア保健福祉研究所は、慢性疾患による年齢標準化死亡率が2021年の人口10万人当たり459人から2022年には490人に増加したと報告しました。その結果、慢性疾患の有病率の増加がドラッグデリバリー技術市場の成長を牽引しています。

ドラッグデリバリー技術市場の主要企業は、患者の利便性を向上させ、投与精度を高め、より安全な薬剤投与を実現するために、プレフィルド注射器などの革新的な製品の開発に注力しています。プレフィルド注射器とは、あらかじめ特定の用量の薬剤が充填された医療機器で、使用前に手作業で薬剤を充填する必要がないです。例えば、2023年2月、米国の医療機器メーカーであるPhillips-Medisize LLC社は、大量生産用に設計された新しい使い捨てペン型注射器を発売しました。この注射器は、カスタマイズ可能な投与量とプッシュボタン式カラーを備えたコンパクトでフレキシブルな設計が特徴で、糖尿病、不妊治療、成長ホルモン、肥満、骨粗鬆症など複数の治療に対応しています。この装置は、費用対効果が高く、すぐに使用できるソリューションを提供することで、製薬会社の市場参入のスピードアップを支援するとともに、商品化コストとリスクを軽減することを目指しています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、貿易戦争と関税、そしてコロナ禍と回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界ドラッグデリバリー技術 PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界のドラッグデリバリー技術市場：成長率分析
• 世界のドラッグデリバリー技術市場の実績：規模と成長, 2019-2024
• 世界のドラッグデリバリー技術市場の予測：規模と成長, 2024-2029, 2034F
• 世界ドラッグデリバリー技術総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界のドラッグデリバリー技術市場：タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 経口
• 注射
• 外用
• 眼科
• 鼻腔
• 肺
• 経粘膜
• 埋め込み型
• 世界のドラッグデリバリー技術市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 心血管疾患
• 腫瘍学
• 泌尿器科
• 糖尿病
• 中枢神経系（CNS）
• 眼科
• 感染症
• その他の用途
• 世界のドラッグデリバリー技術市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院
• クリニック
• 診断センター
• 在宅ケア設定
• その他のエンドユーザー
• 世界のドラッグデリバリー技術市場、経口のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• タブレット
• カプセル
• ソリューション
• サスペンション
• 粉末
• ゲル
• 世界のドラッグデリバリー技術市場、注射のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 従来の注射
• 自己注射
• 長時間作用型注射剤
• 世界のドラッグデリバリー技術市場、トピックのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• クリーム
• ゲル
• ローション
• パッチ
• 軟膏
• 世界のドラッグデリバリー技術市場、眼科のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 目薬
• 軟膏
• ゲル
• 挿入物
• インプラント
• 世界のドラッグデリバリー技術市場、鼻腔のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• スプレー
• ドロップ
• 粉末
• ゲル
• 世界のドラッグデリバリー技術市場、肺のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 定量噴霧式吸入器（MDI）
• ドライパウダー吸入器（DPI）
• ネブライザー
• 世界のドラッグデリバリー技術市場、経粘膜のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 頬側
• 舌下
• 直腸
• 膣
• 世界のドラッグデリバリー技術市場、インプラントのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 生分解性インプラント
• 非生分解性インプラント
• 薬剤溶出ステント

第7章 地域別・国別分析

• 世界のドラッグデリバリー技術市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界のドラッグデリバリー技術市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• ドラッグデリバリー技術市場：競合情勢
• ドラッグデリバリー技術市場：企業プロファイル
  • Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
  • AstraZeneca Plc Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Novartis AG
• GlaxoSmithKline Plc.
• Cipla Limited
• Teva Pharmaceutical Industries Ltd.
• Regeneron Pharmaceuticals, Inc.
• Vertex Pharmaceuticals Incorporated
• Chiesi Farmaceutici S.p.A.
• United Therapeutics Corporation
• Mallinckrodt Pharmaceuticals Plc.
• Lupin Pharmaceuticals, Inc.
• Glenmark Pharmaceuticals Limited
• Alkermes plc.
• Halozyme Therapeutics Inc.
• Sunovion Pharmaceuticals Inc.
• Circassia Pharmaceuticals Plc.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• ドラッグデリバリー技術市場2029：新たな機会を提供する国
• ドラッグデリバリー技術市場2029：新たな機会を提供するセグメント
• ドラッグデリバリー技術市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Drug-delivery technology refers to advanced systems and devices designed to deliver pharmaceutical compounds to specific areas of the body in a controlled and efficient manner. These technologies aim to improve the therapeutic effects of medications, minimize side effects, and enhance patient compliance through various delivery methods, including oral, injectable, transdermal, and implantable systems.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The primary types of drug-delivery technology include oral, injectable, topical, ocular, nasal, pulmonary, transmucosal, and implantable methods. Oral drug delivery involves taking medication via the mouth, typically in the form of tablets or capsules. This method offers convenience and improved effectiveness by utilizing enhanced solubility and absorption technologies. It is used in treating a range of conditions, including cardiovascular diseases, oncology, urology, diabetes, central nervous system (CNS) disorders, ophthalmology, and infections, and is applied in settings such as hospitals, clinics, diagnostic centers, home care, and others.

The drug-delivery technology market research report is one of a series of new reports from The Business Research Company that provides drug-delivery technology market statistics, including the drug-delivery technology industry global market size, regional shares, competitors with the drug-delivery technology market share, detailed drug-delivery technology market segments, market trends, and opportunities, and any further data you may need to thrive in the drug-delivery technology industry. This drug-delivery technology market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The drug-delivery technology market size has grown rapidly in recent years. It will grow from$48.95 billion in 2024 to $54.74 billion in 2025 at a compound annual growth rate (CAGR) of 11.8%. The growth during the historic period can be attributed to the rising demand for targeted drug delivery systems, the increasing prevalence of chronic diseases, the growing adoption of biologics, the higher incidence of respiratory diseases, and the growing popularity of needle-free drug delivery solutions.

The drug-delivery technology market size is expected to see rapid growth in the next few years. It will grow to$84.46 billion in 2029 at a compound annual growth rate (CAGR) of 11.5%. The growth during the forecast period can be attributed to the rise in personalized medicine, an increasing number of regulatory approvals, the growing adoption of smart drug delivery systems, a preference for biodegradable drug carriers, and the rising prevalence of rare diseases. Key trends expected in the forecast period include applications of nanotechnology, patient-centric delivery systems, advancements in inhalation therapies, the use of bioprinting for drug delivery, and the integration of artificial intelligence.

The growing prevalence of chronic diseases is expected to accelerate the growth of the drug-delivery technology market. Chronic diseases are long-term medical conditions that typically progress slowly and require ongoing management. The rise in chronic diseases is largely attributed to sedentary lifestyles, which reduce physical activity and contribute to obesity and other related health issues. Drug-delivery technology plays a critical role in managing chronic diseases by enabling targeted drug delivery, controlled release, improved bioavailability, and reduced side effects, ultimately enhancing treatment effectiveness, patient adherence, and disease management. For example, in June 2024, the Australian Institute of Health and Welfare, an Australian government agency, reported that the age-standardized death rate due to chronic conditions increased from 459 per 100,000 people in 2021 to 490 per 100,000 people in 2022. As a result, the increasing prevalence of chronic diseases is driving the growth of the drug-delivery technology market.

Leading companies in the drug-delivery technology market are focusing on the development of innovative products such as prefilled injection devices to improve patient convenience, enhance dosing accuracy, and ensure safer drug administration. A prefilled injection device is a medical device that comes preloaded with a specific dose of medication, eliminating the need for manual drug filling before use. For example, in February 2023, Phillips-Medisize LLC, a US-based medical equipment manufacturer, launched a new disposable pen injector designed for high-volume manufacturing. The injector features a compact and flexible design with customizable dosing and push-button colors, supporting multiple therapies such as diabetes, fertility, growth hormones, obesity, and osteoporosis. This device aims to help pharmaceutical companies speed up market entry by offering a cost-effective, ready-to-use solution, while also reducing commercialization costs and risks.

In June 2022, Kindeva Drug Delivery L.P., a US-based pharmaceutical manufacturing company, acquired iPharma Labs Inc. for an undisclosed amount. This acquisition is intended to enhance Kindeva Drug Delivery's inhalation formulation outsourcing capabilities, offering a comprehensive portfolio of respiratory delivery expertise and accelerating its one-stop contract development and manufacturing organization (CDMO) approach to support clients from feasibility to commercialization. iPharma Labs Inc., based in the US, specializes in inhalation therapies and drug delivery technologies.

Major players in the drug-delivery technology market are Merck & Co. Inc., AbbVie Inc., Bayer AG, Sanofi S.A., AstraZeneca Plc, Novartis AG, GlaxoSmithKline Plc., Cipla Limited, Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals, Inc., Vertex Pharmaceuticals Incorporated, Chiesi Farmaceutici S.p.A., United Therapeutics Corporation, Mallinckrodt Pharmaceuticals Plc., Lupin Pharmaceuticals, Inc., Glenmark Pharmaceuticals Limited, Alkermes plc., Halozyme Therapeutics Inc., Sunovion Pharmaceuticals Inc., Circassia Pharmaceuticals Plc.

North America was the largest region in the drug-delivery technology market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in drug-delivery technology report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the drug-delivery technology market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The drug-delivery technology market consists of revenues earned by entities by providing services such as custom drug formulation, controlled-release drug delivery systems, injectable drug delivery solutions, nanosystems for drug delivery, and transdermal drug delivery systems. The market value includes the value of related goods sold by the service provider or included within the service offering. The drug-delivery technology market includes sales of microneedle patches, implantable pumps, oral delivery systems, biodegradable drug delivery devices, and liposome-based drug delivery systems. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Drug-Delivery Technology Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on drug-delivery technology market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for drug-delivery technology ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The drug-delivery technology market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Oral; Injectable; Topical; Ocular; Nasal; Pulmonary; Transmucosal; Implantable
• 2) By Application: Cardiovascular Diseases; Oncology; Urology; Diabetes; Central Nervous System (CNS); Ophthalmology; Infections; Other Applications
• 3) By End User: Hospitals; Clinics; Diagnostic Centers; Home Care Settings; Other End Users
• Subsegments:
• 1) By Oral: Tablets; Capsules; Solutions; Suspensions; Powders; Gels
• 2) By Injectable: Conventional Injection; Self-Injection; Long-Acting Injection
• 3) By Topical: Creams; Gels; Lotions; Patches; Ointments
• 4) By Ocular: Eye Drops; Ointments; Gels; Inserts; Implants
• 5) By Nasal: Sprays; Drops; Powders; Gels
• 6) By Pulmonary: Metered Dose Inhalers (MDIs); Dry Powder Inhalers (DPIs); Nebulizers
• 7) By Transmucosal: Buccal; Sublingual; Rectal; Vaginal
• 8) By Implantable: Biodegradable Implants; Non-Biodegradable Implants; Drug-Eluting Stents
• Companies Mentioned: Merck & Co. Inc.; AbbVie Inc.; Bayer AG; Sanofi S.A.; AstraZeneca Plc
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Drug-Delivery Technology Market Characteristics

3. Drug-Delivery Technology Market Trends And Strategies

4. Drug-Delivery Technology Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Drug-Delivery Technology Growth Analysis And Strategic Analysis Framework

• 5.1. Global Drug-Delivery Technology PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Drug-Delivery Technology Market Growth Rate Analysis
• 5.4. Global Drug-Delivery Technology Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Drug-Delivery Technology Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Drug-Delivery Technology Total Addressable Market (TAM)

6. Drug-Delivery Technology Market Segmentation

• 6.1. Global Drug-Delivery Technology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oral
• Injectable
• Topical
• Ocular
• Nasal
• Pulmonary
• Transmucosal
• Implantable
• 6.2. Global Drug-Delivery Technology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cardiovascular Diseases
• Oncology
• Urology
• Diabetes
• Central Nervous System (CNS)
• Ophthalmology
• Infections
• Other Applications
• 6.3. Global Drug-Delivery Technology Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Clinics
• Diagnostic Centers
• Home Care Settings
• Other End Users
• 6.4. Global Drug-Delivery Technology Market, Sub-Segmentation Of Oral, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Tablets
• Capsules
• Solutions
• Suspensions
• Powders
• Gels
• 6.5. Global Drug-Delivery Technology Market, Sub-Segmentation Of Injectable, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Conventional Injection
• Self-Injection
• Long-Acting Injection
• 6.6. Global Drug-Delivery Technology Market, Sub-Segmentation Of Topical, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Creams
• Gels
• Lotions
• Patches
• Ointments
• 6.7. Global Drug-Delivery Technology Market, Sub-Segmentation Of Ocular, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Eye Drops
• Ointments
• Gels
• Inserts
• Implants
• 6.8. Global Drug-Delivery Technology Market, Sub-Segmentation Of Nasal, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Sprays
• Drops
• Powders
• Gels
• 6.9. Global Drug-Delivery Technology Market, Sub-Segmentation Of Pulmonary, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Metered Dose Inhalers (MDIs)
• Dry Powder Inhalers (DPIs)
• Nebulizers
• 6.10. Global Drug-Delivery Technology Market, Sub-Segmentation Of Transmucosal, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Buccal
• Sublingual
• Rectal
• Vaginal
• 6.11. Global Drug-Delivery Technology Market, Sub-Segmentation Of Implantable, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Biodegradable Implants
• Non-Biodegradable Implants
• Drug-Eluting Stents

7. Drug-Delivery Technology Market Regional And Country Analysis

• 7.1. Global Drug-Delivery Technology Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Drug-Delivery Technology Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Drug-Delivery Technology Market

• 8.1. Asia-Pacific Drug-Delivery Technology Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Drug-Delivery Technology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Drug-Delivery Technology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Drug-Delivery Technology Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Drug-Delivery Technology Market

• 9.1. China Drug-Delivery Technology Market Overview
• 9.2. China Drug-Delivery Technology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Drug-Delivery Technology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Drug-Delivery Technology Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Drug-Delivery Technology Market

• 10.1. India Drug-Delivery Technology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Drug-Delivery Technology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Drug-Delivery Technology Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Drug-Delivery Technology Market

• 11.1. Japan Drug-Delivery Technology Market Overview
• 11.2. Japan Drug-Delivery Technology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Drug-Delivery Technology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Drug-Delivery Technology Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Drug-Delivery Technology Market

• 12.1. Australia Drug-Delivery Technology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Drug-Delivery Technology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Drug-Delivery Technology Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Drug-Delivery Technology Market

• 13.1. Indonesia Drug-Delivery Technology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Drug-Delivery Technology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Drug-Delivery Technology Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Drug-Delivery Technology Market

• 14.1. South Korea Drug-Delivery Technology Market Overview
• 14.2. South Korea Drug-Delivery Technology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Drug-Delivery Technology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Drug-Delivery Technology Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Drug-Delivery Technology Market

• 15.1. Western Europe Drug-Delivery Technology Market Overview
• 15.2. Western Europe Drug-Delivery Technology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Drug-Delivery Technology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Drug-Delivery Technology Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Drug-Delivery Technology Market

• 16.1. UK Drug-Delivery Technology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Drug-Delivery Technology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Drug-Delivery Technology Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Drug-Delivery Technology Market

• 17.1. Germany Drug-Delivery Technology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Drug-Delivery Technology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Drug-Delivery Technology Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Drug-Delivery Technology Market

• 18.1. France Drug-Delivery Technology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Drug-Delivery Technology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Drug-Delivery Technology Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Drug-Delivery Technology Market

• 19.1. Italy Drug-Delivery Technology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Drug-Delivery Technology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Drug-Delivery Technology Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Drug-Delivery Technology Market

• 20.1. Spain Drug-Delivery Technology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Drug-Delivery Technology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Drug-Delivery Technology Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Drug-Delivery Technology Market

• 21.1. Eastern Europe Drug-Delivery Technology Market Overview
• 21.2. Eastern Europe Drug-Delivery Technology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Drug-Delivery Technology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Drug-Delivery Technology Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Drug-Delivery Technology Market

• 22.1. Russia Drug-Delivery Technology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Drug-Delivery Technology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Drug-Delivery Technology Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Drug-Delivery Technology Market

• 23.1. North America Drug-Delivery Technology Market Overview
• 23.2. North America Drug-Delivery Technology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Drug-Delivery Technology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Drug-Delivery Technology Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Drug-Delivery Technology Market

• 24.1. USA Drug-Delivery Technology Market Overview
• 24.2. USA Drug-Delivery Technology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Drug-Delivery Technology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Drug-Delivery Technology Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Drug-Delivery Technology Market

• 25.1. Canada Drug-Delivery Technology Market Overview
• 25.2. Canada Drug-Delivery Technology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Drug-Delivery Technology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Drug-Delivery Technology Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Drug-Delivery Technology Market

• 26.1. South America Drug-Delivery Technology Market Overview
• 26.2. South America Drug-Delivery Technology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Drug-Delivery Technology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Drug-Delivery Technology Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Drug-Delivery Technology Market

• 27.1. Brazil Drug-Delivery Technology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Drug-Delivery Technology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Drug-Delivery Technology Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Drug-Delivery Technology Market

• 28.1. Middle East Drug-Delivery Technology Market Overview
• 28.2. Middle East Drug-Delivery Technology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Drug-Delivery Technology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Drug-Delivery Technology Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Drug-Delivery Technology Market

• 29.1. Africa Drug-Delivery Technology Market Overview
• 29.2. Africa Drug-Delivery Technology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Drug-Delivery Technology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Drug-Delivery Technology Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Drug-Delivery Technology Market Competitive Landscape And Company Profiles

• 30.1. Drug-Delivery Technology Market Competitive Landscape
• 30.2. Drug-Delivery Technology Market Company Profiles
  • 30.2.1. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. AstraZeneca Plc Overview, Products and Services, Strategy and Financial Analysis

31. Drug-Delivery Technology Market Other Major And Innovative Companies

• 31.1. Novartis AG
• 31.2. GlaxoSmithKline Plc.
• 31.3. Cipla Limited
• 31.4. Teva Pharmaceutical Industries Ltd.
• 31.5. Regeneron Pharmaceuticals, Inc.
• 31.6. Vertex Pharmaceuticals Incorporated
• 31.7. Chiesi Farmaceutici S.p.A.
• 31.8. United Therapeutics Corporation
• 31.9. Mallinckrodt Pharmaceuticals Plc.
• 31.10. Lupin Pharmaceuticals, Inc.
• 31.11. Glenmark Pharmaceuticals Limited
• 31.12. Alkermes plc.
• 31.13. Halozyme Therapeutics Inc.
• 31.14. Sunovion Pharmaceuticals Inc.
• 31.15. Circassia Pharmaceuticals Plc.

32. Global Drug-Delivery Technology Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Drug-Delivery Technology Market

34. Recent Developments In The Drug-Delivery Technology Market

35. Drug-Delivery Technology Market High Potential Countries, Segments and Strategies

• 35.1 Drug-Delivery Technology Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Drug-Delivery Technology Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Drug-Delivery Technology Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer
• 250617_r34829_Drug_Delivery_Technology_GMR_2025